SEC Filing Summary: AIT Therapeutics, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AIT Therapeutics, Inc., a Delaware corporation, on April 6, 2017, reporting events occurring on March 31, 2017. The filing addresses a change in the company's independent registered public accounting firm.
Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the administrative change of auditors.
Material Changes
- Dismissal of Auditor: The Board of Directors dismissed Heaton & Company, PLLC ("Heaton") as the independent registered public accounting firm, effective March 31, 2017.
- Engagement of New Auditor: Concurrently, the company engaged Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global ("KFGK"), as the new independent registered public accounting firm for the fiscal year ending December 31, 2017.
- Audit History: Heaton's reports for the applicable periods (covering inception through December 31, 2016) did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
- Disagreements: There were no disagreements with Heaton on accounting principles, practices, financial statement disclosures, or auditing scope/procedures during the applicable periods.
- Consultations: The company did not consult with KFGK regarding accounting principles, audit opinions, or reportable events prior to engagement.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of operational risks. The primary contingency noted is the transition of audit responsibilities, which the company states was conducted without unresolved disagreements or reportable events.
Key Facts for Investor Verification
- Verify the effective date of the auditor change (March 31, 2017) and the identity of the new firm (Kost Forer Gabbay & Kasierer).
- Confirm that Heaton & Company, PLLC provided a letter to the SEC (Exhibit 16.1) agreeing with the company's statements regarding the dismissal.
- Note that the filing explicitly states there were no "reportable events" or disagreements with the former auditor.
- Recognize that this filing does not provide updated financial statements or operational metrics.